Pancreatic Cancer

Pancreatic cancer is the third most common cause of cancer death in the United States, with a low 5-year survival rate due to its typically late stage at the time of diagnosis (Surveillance, Epidemiology, and End Results program [SEER]). Fine needle aspiration (FNA) via endoscopic ultrasound (EUS) is the initial diagnostic procedure of choice. Genetic testing for individuals with suspected familial pancreatic cancer may include germline analysis of ATM, BRCA1/BRCA2, and CKDN2A, among others.

Tabs Content
Content Review: 
January 2018

Last Update: October 2019